07-3295. National Institute on Drug Abuse; Notice of Closed Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Imaging of Drug Use Prevention Messages (R21).

    Date: July 24, 2007.

    Time: 8 a.m. to 6 p.m.

    Agenda: To review and evaluate grant applications.

    Place: The Fairmont Washington, DC, 2401 M Street, NW, Washington, DC 20037.

    Contact Person: Mark R. Green, PhD, Deputy Director, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, Md 20892-8401, (301) 435-1431, mgreen1@nida.nih.gov.

    This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs. National Institutes of Health, HHS)

    Start Signature

    Dated: June 29, 2007.

    Anna Snoufer,

    Acting Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 07-3295 Filed 7-05-07; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
7/24/2007
Published:
07/06/2007
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
07-3295
Dates:
July 24, 2007.
Pages:
37031-37031 (1 pages)
PDF File:
07-3295.pdf